Outpatient Care New Albany6199 N. Hamilton Road
Westerville, OH 43081
Suzanne.higginbotham@osumc.edu
(614) 814-8490
Suzanne K. Higginbotham, PharmD, BCACP, CDCES, CTTS is a clinical and research pharmacist at The Ohio State University’s Division of General Internal Medicine. She is a Board-Certified Ambulatory Care Specialist, Certified Diabetes Care and Education specialist, and Certified Tobacco Treatment Specialist.
Dr. Higginbotham’s research focuses on improving health outcomes for patients regarding diabetes care and weight management. Her current studies aim to assess how continuous glucose monitoring in the primary care setting changes health status for patients with
diabetes, and the impact of physicians, pharmacists, and pharmacotherapy working in unison to provide weight management services to patients. Dr. Higginbotham hopes that with her research, the impact of pharmacists working in clinical settings with physicians can improve the health of all patients.
Education and Training
o Academic and Research Fellowship - Ambulatory Care Focus, Duquesne University Mylan School of Pharmacy, Pittsburgh, PA
o Doctor of Pharmacy - Duquesne University Mylan School of Pharmacy, Pittsburgh, PA
o Bachelor of Science - Biology, The Ohio State University, Columbus, OH
Licensures and Certifications
o Certified Diabetes Care and Education Specialist (CDCES)
o Board of Pharmacy Specialties-Ambulatory Care Pharmacy
o Basic Life Support for Healthcare Providers (CPR and AED)
o Pennsylvania Pharmacist License
o Pennsylvania Authorization to Administer Injectables
o Ohio Pharmacist License
o Certified Tobacco Treatment Specialist
Selected Publications
o Wright, QE, Higginbotham SK, Bunk EJ, Covvey JR. “The Impact of a Pharmacist-Led Naloxone Education and Community Distribution Project on Local Use of Naloxone” J Am Pharm Assoc. 2020; 60(3):S56-60.>
o Tedesco GW, McConaha JL, Skomo ML, Higginbotham SK. “A Pharmacist’s Impact on 30-day Readmission Rates when Compared to the Current Standard of Care with a Patient-Centered Medical Home: Pilot Study” J Pharm Pract 2015: 1-6
o Koerner PH, Miller RT, Higginbotham SK. “Development of a Community Residency Program with a Focus on Specialty Pharmacy” Am J Health Syst Pharm 2014; 71:2067-2072
o McConaha JL, Berdine HJ, Skomo ML, Laux RV, Higginbotham SK, O'Neil CK. “Impact of the Fracture Risk Assessment on Patient and Physician Behavior in Osteoporosis Prevention” J Pharm Pract. 2013.
o Witt-Enderby P, Slater JP, Johnson NA, Bondi CD, Balasunder DR, Kotlarcyzk MP, Clafshenkel QP, Sethi S, Higginbotham SK, et. al. “Effects on Bone by the Light/Dark Cycle and Chronic Treatment with Melatonin and/or Hormone Replacement Therapy in Intact Female Mice” Journal of Pineal Research. 2012; 52(4).
o Higginbotham SK, Runyon A, Mattei TJ, Pfalzgraff A. “Impact of a Pharmacist Immunizer on Adult Immunization Rates” J Am Pharm Assoc. 2012; 52(3):367-71.
o Higginbotham SK, Runyon A, Mattei TJ, Pfalzgraff A. “Implementation of an Immunization Needs Assessment in Ambulatory Care.” J Am Pharm Assoc.2010; 50(2) 235. [abstract]
o Ohio Pharmacist “Tune into an Overview of OTC Hearing Aids” co-author. Volume 72, July/August 2023
o The American Pharmacists Association “Using Evidence to Advance Your Practice” Program content developer and reviewer, 2017.